Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nasal mucosal blood vessels consist of arteries, capillaries, venous sinusoids, and arteriovenous anastomoses embedded in the nasal mucosa. They actively participate in warming and humidifying inhaled air, filtering particles, regulating nasal airway patency, and responding dynamically to neural and inflammatory signals. Their volume and tone are critical in conditions such as nasal congestion, rhinitis, and epistaxis. While not a distinct molecular drug target, their function is modified therapeutically by agents affecting vessel tone or inflammation. For structured target databases, "Nasal mucosal blood vessels" should *not* be considered a canonical molecular target, as it is an anatomical complex rather than a receptor, ion channel, enzyme, or similar druggable entity. If a specific vessel cellular component (e.g., α-adrenergic receptor on nasal vessel smooth muscle) is meant, that should be specified as the target.
Vasoconstrictors: activate α-adrenergic receptors on vessel smooth muscle causing vasoconstriction, reducing blood volume and congestion. Steroids/Antihistamines: reduce inflammation, lessen vessel permeability/congestion.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nasal mucosal blood vessel.